Reducing RBM20 activity improves diastolic dysfunction and cardiac atrophy

Impaired diastolic filling is a main contributor to heart failure with preserved ejection fraction (HFpEF), a syndrome with increasing prevalence and no treatment. Both collagen and the giant sarcomeric protein titin determine diastolic function. Since titin’s elastic properties can be adjusted phys...

Full description

Saved in:
Bibliographic Details
Main Authors: Hinze, Florian (Author) , Dieterich, Christoph (Author) , Radke, Michael H. (Author) , Granzier, Henk (Author) , Gotthardt, Michael (Author)
Format: Article (Journal)
Language:English
Published: 26 November 2016
In: Journal of molecular medicine
Year: 2016, Volume: 94, Issue: 12, Pages: 1349-1358
ISSN:1432-1440
DOI:10.1007/s00109-016-1483-3
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00109-016-1483-3
Get full text
Author Notes:Florian Hinze, Christoph Dieterich, Michael H. Radke, Henk Granzier, Michael Gotthardt
Description
Summary:Impaired diastolic filling is a main contributor to heart failure with preserved ejection fraction (HFpEF), a syndrome with increasing prevalence and no treatment. Both collagen and the giant sarcomeric protein titin determine diastolic function. Since titin’s elastic properties can be adjusted physiologically, we evaluated titin-based stiffness as a therapeutic target. We adjusted RBM20-dependent cardiac isoform expression in the titin N2B knockout mouse with increased ventricular stiffness. A ~50 % reduction of RBM20 activity does not only maintain cardiac filling in diastole but also ameliorates cardiac atrophy and thus improves cardiac function in the N2B-deficient heart. Reduced RBM20 activity partially normalized gene expression related to muscle development and fatty acid metabolism. The adaptation of cardiac growth was related to hypertrophy signaling via four-and-a-half lim-domain proteins (FHLs) that translate mechanical input into hypertrophy signals. We provide a novel link between cardiac isoform expression and trophic signaling via FHLs and suggest cardiac splicing as a therapeutic target in diastolic dysfunction.
Item Description:Gesehen am 14.05.2020
Physical Description:Online Resource
ISSN:1432-1440
DOI:10.1007/s00109-016-1483-3